The GENeHOPE Fund, dedicated to groundbreaking research into genetic diseases, is proud to welcome Jo De Wolf, CEO of the publicly listed logistics real estate company Montea, as a new member of its Support Committee.
His decision to join GENeHOPE stems from a deeply personal motivation: the desire to contribute to a meaningful, human-centered, and future-oriented initiative — namely, supporting research into genetic diseases affecting children.
“What personally motivated me is the importance of outstanding research that touches on the most universal form of vulnerability: that of children and their health.”
His commitment also reflects his vision of responsible and engaged leadership. For him, leading goes beyond managing a company — it also means investing in initiatives that make a real difference in the world.
“Joining GENeHOPE aligns perfectly with my values: solidarity, social impact, and collective contribution. I strongly believe the business world has a vital role to play in supporting medical research.”
With his experience as a CEO and his strategic insight, Jo De Wolf will make an entrepreneurial and inspiring contribution to the development of our mission.
The entire GENeHOPE team is thrilled to count on his involvement in this human and scientific journey.
